Get to know Radiation Oncologist Dr. James S. Welsh, who serves patients in Maywood, Illinois.
New York City, Nov 30, 2020 (Issuewire.com) - Dr. Welsh is a highly trained radiation oncologist whose clinical interests include brain tumor, HDR/LDR brachytherapy, lung cancer, prostate cancer, proton therapy, and radiosurgery. He works out of Loyola Outpatient Center & Cardinal Bernardin Cancer Center in Maywood, Illinois.
The Loyola Outpatient Center is located at the south end of the Loyola University Medical Center campus. It brings together dozens of medical services in one location to collaborate on complex clinical issues.
The Cardinal Bernardin Cancer Center is on the east side of the Loyola University Medical Center campus, facing First Avenue and south of the main hospital. It brings together all aspects of cancer care to one site. Beautifully designed for the comfort and convenience of patients, the center also promotes optimal collaboration between healthcare providers.
Professionally, Dr. Welsh is affiliated with Edward Hines, Jr. Veterans Affairs Hospital (serving as Chief of Radiation Oncology), Loyola University Medical Center, and AMITA Health Resurrection Medical Center. He has led research in boron neutron capture therapy and fast neutron therapy when he was the neutron therapy physician at the NIU Institute for Neutron Therapy at Fermilab.
Committed to the education of resident physicians and medical students, he enjoys teaching both at the bedside and in the classroom. He is a Professor at Loyola University Chicago Stritch School of Medicine.
Back in the early days of his academic career, Dr. Welsh graduated with his medical degree from the Renaissance School of Medicine at Stony Brook University in 1990. He then went on to serve his residency in radiation oncology at The Johns Hopkins Hospital. Furthering his training, he completed a fellowship in helical tomotherapy at the University of Wisconsin.
Dedicated to clinical excellence, the doctor is board-certified in radiation oncology by the American Board of Radiology (ABR). The mission of the ABR is to certify that its diplomates demonstrate the requisite knowledge, skill, and understanding of their disciplines to the benefit of patients.
A Fellow of the American College of Radiation Oncology (FACRO), Dr. Welsh is a member of the American College of Radiology, the American Society for Radiation Oncology, the Alpha Omega Alpha Honor Medical Society, and the Society for Brain Mapping and Therapeutics (on the Board of Directors).
Radiation oncology is a medical specialty that involves the controlled use of radiation to treat cancer. It is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. A radiation oncologist is a specialist physician who uses ionizing radiation in the treatment of cancer.
An expert in his field, Dr. Welsh has authored over 100 scientific articles and is a sought-after lecturer. He is the author of "Sharks Get Cancer, Mole Rats Don't: How Animals Could Hold the Key to Unlocking Cancer Immunity in Humans."
In addition, he is the Associate Editor-in-Chief of the Journal of Radiation Oncology, the Associate Editor of the American Journal of Clinical Oncology, the Associate Editor of the Biochemical and Biophysical Journal of Neutron Therapy & Cancer Treatment, and a member of the Editorial Board of Technology in Cancer Research and Treatment.
Learn More about Dr. James S. Welsh:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/737036-James-Welsh-Radiation-Oncologist or through Loyola University Medical Center, https://loyolamedicine.org/doctor/james-welsh
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.
Your Health Contact
Source :James S. Welsh, MD, FACRO
This article was originally published by IssueWire. Read the original article here.